Hikma Pharmaceuticals PLC 2023 AR2
The report highlights Hikma Pharmaceuticals' strong financial and non-financial performance in 2023, with Group revenue increasing by 14% to $2,875 million and core operating profit rising by 19% to $707 million. On the sustainability front, the company achieved a 15% reduction in Scope 1 and 2 greenhouse gas emissions compared to its 2020 baseline, progressing toward its 2030 target of a 25% reduction. Hikma also expanded its social impact by increasing the value of donated medicines by 14% to $4.9 million. Additionally, the company advanced its climate strategy by refining its climate scenario analysis and aligning its disclosures with the TCFD recommendations.
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2023
Type: AR2
Pages: 208
Back to company
Hikma Pharmaceuticals PLC
Annual Report
The report highlights Hikma Pharmaceuticals' strong financial and non-financial performance in 2023, with Group revenue increasing by 14% to $2,875 million and core operating profit rising by 19% to $707 million. On the sustainability front, the company achieved a 15% reduction in Scope 1 and 2 greenhouse gas emissions compared to its 2020 baseline, progressing toward its 2030 target of a 25% reduction. Hikma also expanded its social impact by increasing the value of donated medicines by 14% to $4.9 million. Additionally, the company advanced its climate strategy by refining its climate scenario analysis and aligning its disclosures with the TCFD recommendations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Employees